## Abstract ## Background Intra‐operative hepatic tumor ultrasound assessment can be difficult in patients with abnormal hepatic parenchyma because of the inability to enhance echogenic differences. ## Methods Prospective pilot study of intra‐operative ultrasound contrast enhancement in the eval
Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors
✍ Scribed by Joerg Trojan; Renate Hammerstingl; Knut Engels; Arne R. Schneider; Stefan Zeuzem; Christoph F. Dietrich
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 219 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose.
Contrast‐enhanced ultrasound can differentiate malignant from benign hepatic tumors, but has not been studied in malignant mesenchymal liver tumors.
Methods.
We describe the findings of contrast‐enhanced ultrasound in a cohort of five patients with histological‐proven malignant hepatic mesenchymal tumors.
Results.
The presence of imaging features such as peripheral (nodular) enhancement, chaotic central vascularization, and absence of contrast enhancement in the late phase allowed differentiation from hemangiomas.
Conclusions.
If these findings are demonstrated inlarge hepatic tumors, then the diagnosis of hemangioma is unlikely and further workup is necessary. © 2010 Wiley Periodicals, Inc. J Clin Ultrasound, 2010
📜 SIMILAR VOLUMES
Brain tumors in young children are often extremely difficult to diagnose on clinical grounds. Ultrasound is of proven efficacy in the diagnosis of intracranial hemorrhage,' cystic lesions of the brain,2 and congenital anomalies of the brain.3 In age groups in which a n acoustic window to the brain i
## Abstract Biliary leakage is a serious complication related to T‐tube removal. Identifying the location of the leak is important for accurate diagnosis and prompt treatment. We report a case of biliary leakage in the common bile duct (CBD) following a T‐tube removal that was successfully diagnose
Patients with focal liver lesions (hemangioma, focal nodular hyperplasia, adenoma, hepatocellular carcinoma, metastatic lesions, focal fatty lesion) received the ultrasound contrast agent Levovista (300 mglmL and 400 mg/mL) intravenously. This ultrasound contrast agent (a suspension of micrometer-si
## Purpose: To describe our experience with transrectal ultrasound (trus)-guided needle biopsy of pelvic malignancies. ## Methods: Eleven patients with clinical suspecion of advanced malignant pelvic tumor were referred to our institution with a history of unsuccessful ct-guided biopsy, although